Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.
Saved in:
| Title: | Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer. |
|---|---|
| Authors: | Harshman LC; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Wang X; Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Nakabayashi M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Xie W; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Valenca L; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Werner L; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Yu Y; Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts4Department of Urology, Shanghai Jiao Tong University School of Medicine, Xinhua Hospital, Shanghai, China., Kantoff AM; Apple Tree Partners, New York, New York., Sweeney CJ; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Mucci LA; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts., Pomerantz M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Lee GS; Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Kantoff PW; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts2Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. |
| Source: | JAMA oncology [JAMA Oncol] 2015 Jul; Vol. 1 (4), pp. 495-504. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26181260 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Harshman+LC%22">Harshman LC</searchLink>; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Nakabayashi+M%22">Nakabayashi M</searchLink>; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Xie+W%22">Xie W</searchLink>; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Valenca+L%22">Valenca L</searchLink>; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Werner+L%22">Werner L</searchLink>; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Yu+Y%22">Yu Y</searchLink>; Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts4Department of Urology, Shanghai Jiao Tong University School of Medicine, Xinhua Hospital, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Kantoff+AM%22">Kantoff AM</searchLink>; Apple Tree Partners, New York, New York.<br /><searchLink fieldCode="AU" term="%22Sweeney+CJ%22">Sweeney CJ</searchLink>; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Mucci+LA%22">Mucci LA</searchLink>; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Pomerantz+M%22">Pomerantz M</searchLink>; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Lee+GS%22">Lee GS</searchLink>; Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kantoff+PW%22">Kantoff PW</searchLink>; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts2Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2015 Jul; Vol. 1 (4), pp. 495-504. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26181260 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamaoncol.2015.0829 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 495 Titles: – TitleFull: Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Harshman LC – PersonEntity: Name: NameFull: Wang X – PersonEntity: Name: NameFull: Nakabayashi M – PersonEntity: Name: NameFull: Xie W – PersonEntity: Name: NameFull: Valenca L – PersonEntity: Name: NameFull: Werner L – PersonEntity: Name: NameFull: Yu Y – PersonEntity: Name: NameFull: Kantoff AM – PersonEntity: Name: NameFull: Sweeney CJ – PersonEntity: Name: NameFull: Mucci LA – PersonEntity: Name: NameFull: Pomerantz M – PersonEntity: Name: NameFull: Lee GS – PersonEntity: Name: NameFull: Kantoff PW IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2015 Jul Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 2374-2445 Numbering: – Type: volume Value: 1 – Type: issue Value: 4 Titles: – TitleFull: JAMA oncology Type: main |
| ResultId | 1 |